Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide, a kind of natural product, possesses a wide range o...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in nutrition (Lausanne) 2023-03, Vol.10, p.1107551-1107551
Main Authors: Hu, Yu-Long, Ma, Qiaoli, Dong, Xiaoqiang, Kong, Yuanfang, Cai, Juntao, Li, Jieming, Dong, Chunhong
Format: Article
Language:English
Subjects:
liver diseases
NAFLD
NASH
Nutrition
polysaccharides
therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide, a kind of natural product, possesses a wide range of pharmacological activities. Numerous preclinical studies have confirmed that polysaccharides could interfere with the occurrence and development of NAFLD at multiple interrelated levels, such as improvement of glucose and lipid metabolism, antioxidation, anti-inflammation, and regulation of gut-liver axis, thus showing great potential as novel anti-NAFLD drugs. In this paper, we reviewed the polysaccharides with anti-NAFLD effect in recent years, and also systematically analyzed their possible pharmacological mechanisms.
ISSN:2296-861X
2296-861X
DOI:10.3389/fnut.2023.1107551